- Home
- Medical
- Infectious Diseases
- Antiviral Therapy
Antiviral Therapy
List Price:
$72.99
- Availability: Confirm prior to ordering
- Branding: minimum 50 pieces (add’l costs below)
- Check Freight Rates (branded products only)
Branding Options (v), Availability & Lead Times
- 1-Color Imprint: $2.00 ea.
- Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
- Belly-Band Wrap: $2.50 ea. (full-color printed)
- Set-Up Charge: $45 per decoration
- Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
- Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
- Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
- RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
Product Details
Author:
Dr Eddie Blair, Dr Graham Darby, Dr Gerlad Gough, Dr Eddie Littler, Prof D J Rowlands, Dr Margaret Tisdale
Format:
Paperback
Pages:
176
Publisher:
CRC Press (June 15, 1997)
Language:
English
ISBN-13:
9781859960707
ISBN-10:
1859960707
Weight:
8.5oz
Dimensions:
6.875" x 9.6875"
File:
TAYLORFRANCIS-TayFran_260513043736269-20260513.xml
Folder:
TAYLORFRANCIS
List Price:
$72.99
Case Pack:
16
As low as:
$69.34
Publisher Identifier:
P-CRC
Discount Code:
H
Pub Discount:
30
Country of Origin:
United States
Imprint:
Garland Science
Overview
A concise summary of vital information on drug targets and current therapy regimes for all of the major viral infections. The book brings together in a single volume aspects of antiviral therapy from diverse areas of research and practice, providing up-to-date coverage of recent developments. Starting from an overview of the history of antiviral chemotherapy, the book goes on to describe the development of drugs against HIV, herpesvirus, respiratory viruses, papillomaviruses and hepatitis virus infections. The drugs currently available are reviewed and possible therapies and drug targets for future prophylactic and therapeutic use are discussed.
